页眉背景 AI 页面

REGASK网络研讨会系列

Novel Ingredients, Fragmented Rules: Navigating Infant Formula Regulation Across Markets

In 45 minutes, explore how novel infant formula ingredients are regulated across global markets and what it takes to bring them to market successfully. From differing evidence requirements to market-specific approval pathways, learn how to navigate regulatory complexity with confidence. One ingredient. Multiple pathways. Smarter market entry.

日期: 24 June 2026, Wednesday

时间: 10:00AM – 10:45AM (EST) | 4:00PM – 4:45PM (CET)

地点在线 Teams 网络研讨会

主持人:

Register to attend webinar



网络研讨会回放


首页标题

关于本次网络研讨会

Novel infant formula innovation is accelerating. But regulatory pathways are struggling to keep pace.

Emerging ingredients such as HMOs, bovine lactoferrin, recombinant proteins, and MFGM are opening new opportunities for growth. Yet each market applies its own rules for ingredient authorization, clinical evidence, dossier requirements, product-level obligations, and market entry.

This fragmentation creates real launch risk.

The same ingredient may be ready in one market, delayed by evidence gaps in another, and blocked by sequencing requirements elsewhere. For regulatory teams, successful market entry starts with knowing which pathway applies, what evidence is needed, which approvals come first, and which markets are ready to move.

注册参加

45分钟内您将看到:

浅薰衣草渐变色 4

关于我们的演讲嘉宾

注册参加

加快合规步伐,信心十足

From HMO dossiers to multi-market launches. RegASK maps your regulatory pathway across 160+ territories so your team moves faster and with less risk.

观看 RegASK 的实际演示